10-Hydroxycamptothecin induces apoptosis in human neuroblastoma SMS-KCNR cells through p53, cytochrome c and caspase 3 pathways

Abstract

Neuroblastoma (NB), the most common extracranial solid tumor in childhood, remains one of the most challenging types of cancer to treat. Therefore, the search for novel effective drugs for its treatment is essential. The present study used 10-hydroxycamptothecin (HCPT), which is a naturally occurring alkaloid anticancer agent extracted from the Chinese tree, Camptotheca acuminata, and has a strong anticancer activity in vitro and in vivo. HCPT is able to induce apoptosis in cells of various tumor types. However, few studies have been conducted on its efficacy in NB, and its apoptosis-inducing mechanism has not been elucidated. In the present study, the in vitro effects of HCPT on apoptosis in the human NB cell line, SMS-KCNR, and its underlying molecular mechanisms were investigated. Cell proliferation was measured by an MTT assay and apoptosis was measured using DAPI staining and flow cytometric analysis. In addition, western blot analysis was used to evaluate the apoptosis-associated signaling pathways. HCPT was observed to markedly inhibit cell proliferation and induce apoptosis in SMS-KCNR cells at a relatively low concentration (2.5-20 nM). DAPI staining revealed typical apoptotic feature, namely apoptotic body formation. The flow cytometric analysis revealed that the number of apoptotic cells increased from 20.89% (for 2.5 nM) to 97.66% (for 20 nM) following HCPT treatment for 48 h. Western blot analysis revealed that p53, cytoplasmic cytochrome c, cleaved caspase-3 and poly ADP-ribose polymerase (PARP) proteins were significantly upregulated, while the mitochondrial cytochrome c and pro-caspase-3 proteins were downregulated. However, the B-cell lymphoma 2 and Bcl-2-associated X proteins were unaffected. The results indicated that HCPT may inhibit proliferation and induce apoptosis in the SMS-KCNR cells. The possible mechanism of apoptosis induction is the p53-mediated mitochondrial apoptotic signaling pathway, which promotes cytochrome c release and induces apoptosis by activating caspase-3 and PARP. Our study provides experimental evidence for HCPT as a potent therapeutic drug in NB treatment.

Influence of Tanshinone IIA on apoptosis of human esophageal carcinoma Eca‐109 cells and its molecular mechanism

“…Our study also displayed CytC overexpression after Eca cells were treated with Tan IIA (20, 40, 60 μg/mL) for 72 hours (Figs ). These results are consistent with findings by other researchers, implying that CytC overexpression most probably participates in Tan IIA‐induced Eca‐109 cell apoptosis . It is well known that caspase activation is generally considered a key characteristic of apoptosis.…”

Escitalopram oxalate induces apoptosis in U‐87MG cells and autophagy in GBM8401 cells

“…PARP can also induce programmed cell death by producing poly-ADP-ribose [PAR] through stimulating mitochondria to release apoptosis-inducing factor (AIF) [31]. Herein, PARP promoted the inhibition of Bcl-2 and triggered the release of Bax and cytochrome C (Cyt-C), promoting apoptosis [32,33]. In this study, cytotoxic activity of escitalopram oxalate was initiated by activating caspase-8 and cleaving caspase-3, resulting in the proteolytic cleavage of PARP in U-87MG cells.…”

Anticancer effects of 10-hydroxycamptothecin induce apoptosis of human osteosarcoma through activating caspase-3, p53 and cytochrome�c pathways

“…In the present study, it was revealed that HCPT effectively promoted caspase-3/9 activities and inhibited the protein expression of Bcl-2 in human osteosarcoma MG-63 cells. Yuan et al (12) had previously indicated that HCPT induces apoptosis through the p53, cytochrome c and caspase-3 pathways of human neuroblastoma SMS-KCNR cells.…”

“…The primary negative effects include myelosuppression and a gastrointestinal reaction. These effects are due to dose-limiting toxicity (12). Currently, HCPT is primarily used in the form of a sodium salt injection.…”